Download free PDF
Ophthalmic Devices Market - By Product, By End Use - Global Forecast, 2025 - 2034
Report ID: GMI2917
|
Published Date: October 2025
|
Report Format: PDF
Download Free PDF
Authors: Mariam Faizullabhoy , Gauri Wani
Premium Report Details
Base Year: 2024
Companies covered: 16
Tables & Figures: 320
Countries covered: 19
Pages: 140
Download Free PDF
Ophthalmic Devices Market
Get a free sample of this report
Get a free sample of this report Ophthalmic Devices Market
Is your requirement urgent? Please give us your business email
for a speedy delivery!

Ophthalmic Devices Market Size
The global ophthalmic devices market was estimated at USD 48.7 billion in 2024. The market is expected to grow from USD 50.2 billion in 2025 to USD 72.7 billion in 2034, at a CAGR of 4.2% during the forecast period, according to the latest report published by Global Market Insights Inc. The market is driven by growing demand and preference for minimally invasive surgeries, an increase in the number of people suffering from ophthalmic disorders, technological advancements in products, and rising adoption of contact lenses and spectacles, among other factors.
The rise in the number of procedures for different ophthalmic disorders, the focus on early diagnosis, and the surging geriatric population are among the key variables fueling the market growth. Essilor, Alcon, ZEISS, Johnson & Johnson, CooperVision, and Bausch+Lomb are among the leading players operating in the market. These players mainly focus on product innovation, expanding their product offering and distribution network, and improving patient comfort, enabling ophthalmic clinics worldwide to improve efficiency and service quality.
The market grew from USD 44.6 billion in 2021 to USD 47.1 billion in 2023. Rising prevalence of vision problems, such as nearsightedness, farsightedness, and astigmatism, has led more people to opt for contact lenses and spectacles. Modern urban lifestyles, prolonged screen time, and the shift to online learning have contributed to a surge in vision-related issues, particularly among younger populations. Consumers increasingly demand eyewear that combines style and functionality, prompting companies to enhance lens materials, coatings, and designs. Additionally, there is growing adoption of daily disposable contact lenses, smart lenses, and blue-light filtering glasses.
Innovations in ophthalmic devices have transformed how doctors diagnose and treat eye conditions, leading to better outcomes for patients. Advanced technologies such as optical coherence tomography (OCT), femtosecond lasers, and AI-powered imaging systems help doctors detect eye problems earlier and treat them with minimal invasion. For instance, according to recent trials in Australia, AI-powered eye scans recorded a significant 93% accuracy in detecting diabetic eye disease.
The introduction of smart contact lenses and wearable vision aids gives patients access to real-time monitoring and a better experience. These improvements make eye care procedures more efficient, reduce healing time, and lower the risk of complications, helping more people access quality eye care. As research continues and digital health tools become more integrated, the market is expected to grow further.
Eye disorders such as cataracts, glaucoma, diabetic retinopathy, and age-related macular degeneration continue to affect more people worldwide. For instance, according to the data reported by the World Glaucoma Association, the number of patients suffering from glaucoma is expected to reach over 111 million by 2040. People over 60 face a higher risk of vision problems as they age. Modern lifestyle choices, like spending long hours in front of screens, poor dietary habits, and health conditions such as diabetes, make people more susceptible to eye problems at an earlier age. As more people seek treatment for these conditions, the need for diagnostic tools, surgeries, and vision correction products has grown substantially.
Ophthalmic devices are specialized medical tools that doctors use to diagnose, monitor, and treat various eye conditions and diseases. These devices range from surgical instruments to advanced diagnostic equipment. They also include everyday vision correction products such as contact lenses and intraocular lenses. Healthcare professionals rely on these devices to help patients with eye disorders such as cataracts, glaucoma, and refractive errors, working to restore or improve their vision.
Around 15%
Collective market share in 2024 is ~ 45%
Ophthalmic Devices Market Trends
The market evolves as demands for better care and new technologies for the target population rise. By integrating artificial intelligence (AI) and machine learning in their diagnostic instruments, physicians are able to diagnose eye diseases in a shorter timeframe with improved precision and also generate individualized treatment plans, particularly for patients with glaucoma and diabetic retinopathy.
Ophthalmic Devices Market Analysis
In 2021, the market was valued at USD 44.6 billion, rising to USD 45.8 billion in 2022 and reaching USD 47.1 billion by 2023. Increasing awareness among the younger population, the availability of affordable, high-quality treatments in developing countries, and the growing adoption of contact lenses are expected to drive the market growth.
Based on product, the global ophthalmic devices market is segmented into vision care products, surgical devices, diagnostic and monitoring devices, and ophthalmic accessories. The vision care products segment accounted for a leading share of 51.9% in 2024. The vision care products segment is further bifurcated into spectacle lenses and contact lenses. Increasing need for spectacles and lenses due to longer working hours over digital devices among a significant percentage of individuals worldwide is projected to fuel the product demand. The segment is expected to exceed USD 37.3 billion by 2034, growing at a CAGR of 4.1% during the forecast period.
Based on end use, the ophthalmic devices market is segmented into consumers, hospitals, specialty clinics, ambulatory surgery centers, and other end users. The consumer segment accounted for the majority market share of 47.8% in 2024 due to growing adoption of vision care products such as spectacles and lenses among younger age groups.
North America Ophthalmic Devices Market
North America market accounted for a leading share of 36.8% in 2024 in the global market and is anticipated to show lucrative growth over the forecast period.
The U.S. ophthalmic devices market was valued at USD 15.5 billion and USD 15.8 billion in 2021 and 2022, respectively. In 2024 the market size was valued at USD 16.6 billion from USD 16.1 billion in 2023. The significant focus on early disease diagnosis from the local population due to high disease burden is a key variable in fueling the market growth.
Europe Ophthalmic Devices Market
Europe accounted for a substantial share in the market and was valued at USD 13.7 billion in 2024.
UK held significant share of the European ophthalmic devices market, showcasing strong growth potential.
Asia Pacific Ophthalmic Devices Market
The Asia Pacific market is anticipated to grow at the highest CAGR of 5.1% during the analysis timeframe.
China ophthalmic devices market is estimated to grow with a healthy CAGR in the Asia Pacific market.
Latin America Ophthalmic Devices Market
Brazil leads the Latin American market, exhibiting remarkable growth during the analysis period.
Middle East and Africa Ophthalmic Devices Market
Saudi Arabia market is expected to experience substantial growth in the Middle East and Africa market in 2024.
Ophthalmic Devices Market Share
Leading companies operating in the market, such as Alcon, Essilor, ZEISS, Johnson & Johnson, and Bausch+Lomb, among others, have a significant presence in the industry. These players maintain their key position by combining a strong product portfolio, regulatory clearances, wide distribution capability, and partnerships with local players.
Surgical devices, especially intraocular lenses (IOLs) and phacoemulsification systems, hold a substantial market share as more patients undergo cataract surgeries. Diagnostic devices such as optical coherence tomography (OCT) systems have become essential tools for doctors to detect diseases early and accurately. Vision care products, such as contact lenses and spectacles, remain fundamental to the market's financial health.
As industry evolves, artificial intelligence in diagnostic tools, tele-ophthalmology services, and minimally invasive surgical techniques are changing how doctors treat patients. Medical device companies now focus on developing portable, smaller, more efficient equipment with built-in analytics to better serve patients in outpatient settings.
Further, while FDA and CE regulations continue to set high standards for market entry, affecting products time-to-market and their costs, new opportunities emerge in developing markets. This encourages companies to develop products that are both affordable and easy to transport, helping more people access quality eye care.
Ophthalmic Devices Market Companies
Few of the prominent players operating in the global ophthalmic devices industry include:
Essilor held a leading position in the ophthalmic devices market with a share of around 15% in 2024. Essilor Luxottica leverages a vertically integrated business model, combining lens technology and iconic eyewear under one roof. The company develops medical wearables, manages popular eyewear brands, and promotes sustainable practices. By integrating most of the processes from manufacturing to retail stores and online sales, EssilorLuxottica makes sure people worldwide can access quality vision care.
Alcon helps patients through two main operational categories, including surgical innovation and vision care. Its surgical division creates advanced intraocular lenses and develops minimally invasive procedures, while the vision care team works on digital tools and high-quality contact lenses. The company uses artificial intelligence to improve diagnostics and works closely with insurance providers to make treatments more accessible, especially in developing countries.
Johnson & Johnson's MedTech team focuses on creating new medical solutions and reaching more patients globally. They plan to introduce many new products by 2027, including advances in robotics, digital health, and surgical technologies. The company carefully invests its resources, acquires promising companies, and develops new treatments for growing medical needs.
Ophthalmic Devices Industry News:
The global ophthalmic devices market research report includes an in-depth coverage of the industry with estimates and forecasts in terms of revenue in (USD Million) from 2021 - 2034 for the following segments:
Click here to Buy Section of this Report
Market, By Product
Market, By End Use
The above information is provided for the following regions and countries: